Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis

Launched by COORDINACIÓN DE INVESTIGACIÓN EN SALUD, MEXICO · Oct 2, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how continuous glucose monitoring can help manage blood sugar levels in patients with Type 2 diabetes who are on peritoneal dialysis. The aim is to understand how different factors, like the type and timing of insulin used, affect blood sugar patterns throughout the day. Patients will wear a small sensor that tracks their glucose levels continuously for 14 days, allowing doctors to gather important information that can improve diabetes care and reduce complications.

To participate in this study, individuals must be over 40 years old, diagnosed with diabetic nephropathy (a kidney-related complication of diabetes), and reliant on insulin for controlling their blood sugar. They should also have been receiving peritoneal dialysis for at least three months. During the trial, participants will have their glucose levels monitored regularly, and their dietary habits and insulin usage will also be recorded. It's a way to help find better strategies to manage diabetes and improve overall health for those undergoing this treatment.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: Participants over 40 years of age, of any sex, diagnosed with Diabetic Nephropathy, and who are exclusively insulin-dependent for metabolic control, with at least three months of PD treatment.
• • Exclusion Criteria: Patients with positive serology for HIV and hepatitis B and C, acute complications, and hospitalization for cardiovascular, metabolic or infectious disease in the month prior to inclusion in the study, cancer, pregnancy, or allergy.